230 related articles for article (PubMed ID: 23305154)
1. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles.
Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
Biomacromolecules; 2013 Feb; 14(2):557-63. PubMed ID: 23305154
[TBL] [Abstract][Full Text] [Related]
2. Applications of chitosan nanoparticles in drug delivery.
Tajmir-Riahi HA; Nafisi Sh; Sanyakamdhorn S; Agudelo D; Chanphai P
Methods Mol Biol; 2014; 1141():165-84. PubMed ID: 24567139
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic doxorubicin and its derivative bind milk β-lactoglobulin.
Agudelo D; Beauregard M; Bérubé G; Tajmir-Riahi HA
J Photochem Photobiol B; 2012 Dec; 117():185-92. PubMed ID: 23147200
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of milk β-lactoglobulin by chitosan nanoparticles.
Agudelo D; Nafisi S; Tajmir-Riahi HA
J Phys Chem B; 2013 May; 117(21):6403-9. PubMed ID: 23651207
[TBL] [Abstract][Full Text] [Related]
5. Transporting antitumor drug tamoxifen and its metabolites, 4-hydroxytamoxifen and endoxifen by chitosan nanoparticles.
Agudelo D; Sanyakamdhorn S; Nafisi S; Tajmir-Riahi HA
PLoS One; 2013; 8(3):e60250. PubMed ID: 23527310
[TBL] [Abstract][Full Text] [Related]
6. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications.
Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA
Int J Biol Macromol; 2014 May; 66():144-50. PubMed ID: 24560949
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of doxorubicin-polymer conjugates.
Sanyakamdhorn S; Bekale L; Agudelo D; Tajmir-Riahi HA
Colloids Surf B Biointerfaces; 2015 Nov; 135():175-182. PubMed ID: 26255162
[TBL] [Abstract][Full Text] [Related]
8. tRNA binding to antitumor drug doxorubicin and its analogue.
Agudelo D; Bourassa P; Beauregard M; Bérubé G; Tajmir-Riahi HA
PLoS One; 2013; 8(7):e69248. PubMed ID: 23922696
[TBL] [Abstract][Full Text] [Related]
9. Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins.
Agudelo D; Bourassa P; Bruneau J; Bérubé G; Asselin E; Tajmir-Riahi HA
PLoS One; 2012; 7(8):e43814. PubMed ID: 22937101
[TBL] [Abstract][Full Text] [Related]
10. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.
Jeong YI; Jin SG; Kim IY; Pei J; Wen M; Jung TY; Moon KS; Jung S
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):149-55. PubMed ID: 20427160
[TBL] [Abstract][Full Text] [Related]
13. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
[TBL] [Abstract][Full Text] [Related]
16. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker.
Lavignac N; Nicholls JL; Ferruti P; Duncan R
Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
18. Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.
Yousefpour P; Atyabi F; Farahani EV; Sakhtianchi R; Dinarvand R
Int J Nanomedicine; 2011; 6():1487-96. PubMed ID: 21796249
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
